Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Luisa Gutierrez M, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Josef Maria Bauer D, Benjamin Mauz J, Casanova-Cabral M, Gschwantler M, Paolo Russo F, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M; cACLD-SVR Study Group (in alphabetical order).
Semmler G, et al. Among authors: ahumada a.
J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.03.015. Online ahead of print.
J Hepatol. 2024.
PMID: 38521170
Free article.